Introduction
Angiogenesis and the growth of lymphatic vessels, lymphangiogenesis, are likely to involve similar processes, though formal evidence of this assertion has yet to be published. Studies on lymphatic ontogeny raised the hypothesis that the lymphatic system arises through the progressive sprouting of EC from embryonic veins [8] . Currently, there is much debate whether lymphatic progenitor cells may contribute to post-natal lymph vessel formation. In human beings, two potential candidates for lymphatic progenitor cells have been identified so far. Salven et al. [9] [8] .
single thin layer of overlapping and attenuated EC that lack a continuous basal membrane and pericyte coverage. Functionally, the lymphatic endothelium controls tissue fluid homeostasis by draining protein-rich lymph from tissues and organs and elicits an immune function by transporting antigens in a free form or associated with dendritic cells as carriers from the peripheral tissues to the lymphoid organs. Also, it serves as a major route for absorption of fat from the small intestine and provides a pathogenic pathway for tumour metastasis

For future therapeutic use of EPC, further basic information is essential. In the present study, we aimed to increase knowledge of EPC-derived cells by comparing their phenotypic, functional and gene expression properties with those of human dermal lymphatic endothelial cells (HDLEC) and human umbilical vein endothelial cells (HUVEC). We have chosen human umbilical cord blood CD133
+ CD34 + cells as EPC because they are easier to obtain both in a higher number and cell-cycle rate than it is the case for the isolation of haematopoietic progenitors from the adult peripheral blood. (Fig. 2) . Figure 3 (Fig. 4) . Interestingly, CD133 and CD34 were still present on the surface of HDLEC, although CD133 was detected at a significantly lower level than CD34 (Fig. 3) . Contrarily, HUVEC showed weak expression of CD34 and loss of CD133 (Fig. 3) . (Fig. 5) (Fig. 6 ). (Fig. 7B) . The same results were observed in HDLEC and HUVEC.
Material and methods
Generation of EPC-derived cells from human umbilical cord blood
Immunostaining of EPC-derived cells on cytospin preparations
Endothelial network formation in Matrigel
Western blot analysis
Phenotypic characterization of EPC-derived cells In order to determine the phenotype of EPC-derived cells, we performed flow cytometry and immunohistochemistry analysis using a selected set of markers and compared it to that obtained in HDLEC and HUVEC. The cell surface expression of molecules is summarized in
illustrating the major phenotypic differences between the EC types. By FACS analysis, EPC-derived cells were strongly positive for common endothelial markers such as CD31, CD54, CD105 and CD144. These results clearly indicate that the cord blood-derived CD34 + cells had undergone a complete EC differentiation process. In addition, EPC-derived cells were weakly positive for thrombomodulin and CD143 and failed to express CD36. Several cell surface endothelial markers were similarly expressed on HDLEC and HUVEC. Among them were CD31, CD54, CD105 and CD144. Other markers differentiated EPC-derived cells from the other EC types. Unlike EPC-derived cells, HDLEC abundantly expressed CD36, while CD36 was absent on HUVEC. In general, EPC-derived cell cultures did not contain monocytes or macrophages as attested by the absence of CD14 + cells.
Differentiation into EC was further associated with the acquisition of HLA-class I antigens, but not HLA-class II antigens. In the line with this observation, EPC-derived cells efficiently expressed ␤2-microglobulin, which is the light chain of the HLA-class I antigen complex and was much more strongly expressed on HDLEC. Freshly isolated cord blood CD34 + cells expressed high levels of the progenitor cell marker CD133. During differentiation, the expression of CD133 and CD34 progressively decreased and was no longer detectable on terminally matured EPC-derived cells
To examine whether EPC-derived cells have phenotypes of lymphatic EC, EPC-derived cells were subjected to immunocytochemistry. Analyses on cytospins revealed that EPC-derived cells were positively stained for the panendothelial marker CD31 and vWF, but negatively stained for the lymphatic cell-specific markers podoplanin and Prox-1. Surprisingly, a minor subset of EPCderived cells reacted with the lymphatic cell-specific marker LYVE-1, indicating their origin from haematopoietic stem cells
Functional characteristics of EPC-derived cells We tested whether EPC-derived cells would up-regulate expression of the cell adhesion molecules CD54 and CD62E when exposed to TNF-␣, which is a characteristic feature of EC. Incubation of EPC-derived cells with varying TNF-␣ concentrations (100 U/ml, 200 U/ml and 500 U/ml) for 4 and 24 hrs led to a markedly increased expression of both CD54 and CD62E (Fig. 7A). Treatment of HDLEC and HUVEC with TNF-␣ resulted in a similar dose and time response. However, in contrast to HDLEC and HUVEC, no decrease of CD62 expression was seen on EPCderived cells after 5 hrs stimulation with TNF-␣, indicating that the EPC-derived cells share similarities with mature EC, but are not alike (data not shown). Furthermore, EPC-derived cells efficiently incorporated DiI-ac-LDL, which is another important function of mature EC
The ability to form networks in Matrigel is also a hallmark of EC behaviour. Accordingly, we evaluated EPC-derived cells in network formation assays using Matrigel. Within 24 hrs of incubation, EPC-derived cells assembled into a capillary-like network on a
Matrigel-coated surface, indistinguishable from those formed by HDLEC and HUVEC under the same conditions (Fig. 7C) . [12] . In fact, both EC types expressed a similar profile of EC-specific antigens, including CD31, vWF, CD105 and CD144 [13, 14] [22, 23] and by the lack of lymphatic cell-specific markers podoplanin, Prox-1 and VEGFR-3 as well [9, 24, 25] . Since LYVE-1 expression is not restricted to lymphatic endothelium, but is found also on macrophages and dendritic cells, the sporadic detection of LYVE-1 on EPC-derived cells can be explained by their haematopoietic origin [26] .
Comparative gene array analyses of cultured EPC-derived cells and HDLEC Global gene expression patterns among EPC-derived cells and HDLEC populations were analysed to determine lineage
Fig. 2 Weibel-Palade bodies in cord blood CD34 + -derived EPC-derived cells. (B) and (D) show Weibel-Palade bodies in the cell that is depicted at low power in (A). Note the typical internal structure of the bodies. For comparison, (C) shows a Weibel-Palade body from a dermal EC in healthy human skin in situ. (B-D) are at the same magnification. Final magnifications: (A) ϫ6.200, (B-D) ϫ90.000; scale bars correspond to 2 m in (A) and 100 nm in (B-D).
Fig. 3 Comparative expression of surface markers in cultured EPC
Microarray expression data were generally in agreement with previous reports and confirmed the vascular endothelial phenotype of EPC-derived cells [10, 15] . While podoplanin was exclusively expressed in HDLEC, EPC-derived cells showed no gene expression A, B, E, F) ϫ400, (B, C) 
Fig. 5 Immunofluorescence analysis of EPC-derived cells. Cells were positively stained for the panendothelial marker CD31 (A) and vWF (B), but negatively stained for the lymphatic cell-specific markers podoplanin and Prox-1 (C, D). Note that some few EPC-derived cells showed expression of the lymphatic cell-specific marker LYVE-1 (E, F). Original magnifications: (
